Should Value Investors Buy Scor (SCRYY) Stock?

18.12.25 15:40 Uhr

Werte in diesem Artikel

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.Scor (SCRYY) is a stock many investors are watching right now. SCRYY is currently sporting a Zacks Rank #2 (Buy), as well as an A grade for Value. The stock is trading with P/E ratio of 7.48 right now. For comparison, its industry sports an average P/E of 9.19. Over the past year, SCRYY's Forward P/E has been as high as 28.38 and as low as -302.80, with a median of 7.31. Another notable valuation metric for SCRYY is its P/B ratio of 1.25. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 2.68. Over the past 12 months, SCRYY's P/B has been as high as 1.32 and as low as 0.76, with a median of 1.01.Investors could also keep in mind SiriusPoint (SPNT), another Insurance - Multi line stock with a Zacks Rank of #2 (Buy) and Value grade of A.SiriusPoint sports a P/B ratio of 1.08 as well; this compares to its industry's price-to-book ratio of 2.68. In the past 52 weeks, SPNT's P/B has been as high as 1.33, as low as 0.84, with a median of 1.03.These are just a handful of the figures considered in Scor and SiriusPoint's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that SCRYY and SPNT is an impressive value stock right now.Zacks Naming Top 10 Stocks for 2026Want to be tipped off early to our 10 top picks for the entirety of 2026? History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2026. Don’t miss your chance to get in on these stocks when they’re released on January 5. Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Scor SE (SCRYY): Free Stock Analysis Report SiriusPoint Ltd. (SPNT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf SCOR

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf SCOR

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu SCOR SE Prov. Regpt.

Wer­bung

Analysen zu SCOR SE Prov. Regpt.

DatumRatingAnalyst
07.09.2020SCOR SE Prov Regpt NeutralJP Morgan Chase & Co.
11.09.2013SCOR SE Prov Regpt kaufenCommerzbank AG
25.04.2013SCOR SE Prov Regpt verkaufenMorgan Stanley
18.03.2013SCOR SE Prov Regpt verkaufenCredit Suisse Group
21.01.2013SCOR SE Prov Regpt haltenGoldman Sachs Group Inc.
DatumRatingAnalyst
11.09.2013SCOR SE Prov Regpt kaufenCommerzbank AG
14.11.2012SCOR SE Prov Regpt outperformExane-BNP Paribas SA
14.11.2012SCOR SE Prov Regpt buyNomura
07.09.2012SCOR SE Prov Regpt buyNomura
07.09.2012SCOR SE Prov Regpt buySociété Générale Group S.A. (SG)
DatumRatingAnalyst
07.09.2020SCOR SE Prov Regpt NeutralJP Morgan Chase & Co.
21.01.2013SCOR SE Prov Regpt haltenGoldman Sachs Group Inc.
16.11.2012SCOR SE Prov Regpt neutralJ.P. Morgan Cazenove
19.10.2012SCOR SE Prov Regpt neutralJ.P. Morgan Cazenove
07.09.2012SCOR SE Prov Regpt neutralJ.P. Morgan Cazenove
DatumRatingAnalyst
25.04.2013SCOR SE Prov Regpt verkaufenMorgan Stanley
18.03.2013SCOR SE Prov Regpt verkaufenCredit Suisse Group
24.10.2012SCOR SE Prov Regpt underperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für SCOR SE Prov. Regpt. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen